Welcome to LookChem.com Sign In|Join Free

CAS

  • or

790304-84-6

Post Buying Request

790304-84-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

790304-84-6 Usage

Uses

6-isopropylisoquinoline is a heterocyclic organic compound and can be used as a pharmaceutical intermediate.

Check Digit Verification of cas no

The CAS Registry Mumber 790304-84-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,9,0,3,0 and 4 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 790304-84:
(8*7)+(7*9)+(6*0)+(5*3)+(4*0)+(3*4)+(2*8)+(1*4)=166
166 % 10 = 6
So 790304-84-6 is a valid CAS Registry Number.

790304-84-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-isopropylisoquinoline

1.2 Other means of identification

Product number -
Other names 6-isopropyl-isoquinoline

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:790304-84-6 SDS

790304-84-6Synthetic route

6-bromo-isoquinoline
34784-05-9

6-bromo-isoquinoline

isopropylmagnesium chloride
1068-55-9

isopropylmagnesium chloride

6-isopropylisoquinoline
790304-84-6

6-isopropylisoquinoline

Conditions
ConditionsYield
Stage #1: isopropylmagnesium chloride With zinc(II) chloride In tetrahydrofuran at 0℃; for 1.5h; Inert atmosphere;
Stage #2: With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride In tetrahydrofuran for 0.25h;
Stage #3: 6-bromo-isoquinoline In tetrahydrofuran for 12h;
75%
N-[(4-isopropylphenyl)methylene]-2,2-dimethoxyethanamine

N-[(4-isopropylphenyl)methylene]-2,2-dimethoxyethanamine

6-isopropylisoquinoline
790304-84-6

6-isopropylisoquinoline

Conditions
ConditionsYield
Stage #1: N-[(4-isopropylphenyl)methylene]-2,2-dimethoxyethanamine With sulfuric acid at 140℃; for 0.333333h;
Stage #2: With sodium hydroxide In water
15%
With sulfuric acid at 100℃; for 0.5h;
6-isopropylisoquinoline
790304-84-6

6-isopropylisoquinoline

diethyl dicarbonate
1609-47-8

diethyl dicarbonate

dimethyl diazomethylphosphonate
27491-70-9, 28447-24-7, 25411-73-8

dimethyl diazomethylphosphonate

ethyl (R)-1-(diazo(dimethoxyphosphoryl)methyl)-6-isopropylisoquinoline-2(1H)-carboxylate

ethyl (R)-1-(diazo(dimethoxyphosphoryl)methyl)-6-isopropylisoquinoline-2(1H)-carboxylate

Conditions
ConditionsYield
With (R)-6,6’-bis(3',4',5'-trifluoro-2,6-dimethyl[1,1'-biphenyl]-4-yl)-1,1'-spirobiindane-7,7'-diyl phosphate In toluene at -30℃; for 56h; Inert atmosphere; Molecular sieve; enantioselective reaction;97%
6-isopropylisoquinoline
790304-84-6

6-isopropylisoquinoline

6-isopropyl-1,2,3,4-tetrahydroisoquinoline hydrochloride
935542-80-6

6-isopropyl-1,2,3,4-tetrahydroisoquinoline hydrochloride

Conditions
ConditionsYield
Stage #1: 6-isopropylisoquinoline With hydrogen; acetic acid; platinum(IV) oxide for 72h;
Stage #2: With hydrogenchloride In 1,4-dioxane
95%
diazoacetic acid ethyl ester
623-73-4

diazoacetic acid ethyl ester

6-isopropylisoquinoline
790304-84-6

6-isopropylisoquinoline

diethyl dicarbonate
1609-47-8

diethyl dicarbonate

ethyl (R)-1-(1-diazo-2-ethoxy-2-oxoethyl)-6-isopropylisoquinoline-2(1H)-carboxylate

ethyl (R)-1-(1-diazo-2-ethoxy-2-oxoethyl)-6-isopropylisoquinoline-2(1H)-carboxylate

Conditions
ConditionsYield
With (R)-6,6’-bis((4-(tert-butyl)-2-methylphenyl))-1,1'-spirobiindane-7,7'-diyl phosphate In toluene at -20℃; for 88h; Inert atmosphere; Molecular sieve; enantioselective reaction;78%
6-isopropylisoquinoline
790304-84-6

6-isopropylisoquinoline

C12H13NO

C12H13NO

Conditions
ConditionsYield
With dihydrogen peroxide; acetic acid at 80℃; for 12h;60%
6-isopropylisoquinoline
790304-84-6

6-isopropylisoquinoline

triethylsilyloxydiethyl phosphonic ester
13716-46-6

triethylsilyloxydiethyl phosphonic ester

2,2,2-Trichloroethyl chloroformate
17341-93-4

2,2,2-Trichloroethyl chloroformate

A

C19H25Cl3NO5P

C19H25Cl3NO5P

B

C19H25Cl3NO5P

C19H25Cl3NO5P

Conditions
ConditionsYield
With 1-((S)-1-(N-benzyl-N-methylcarbamoyl)-2,2-dimethylpropyl)-3-(3,5-bis(trifluoromethyl)phenyl)thiourea In toluene at -50℃; for 72h; Overall yield = 87 %; enantioselective reaction;A n/a
B n/a
6-isopropylisoquinoline
790304-84-6

6-isopropylisoquinoline

1-chloro-6-isopropylisoquinoline
630422-59-2

1-chloro-6-isopropylisoquinoline

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: acetic acid; dihydrogen peroxide / 12 h / 80 °C
2: trichlorophosphate / 6 h / 50 °C
View Scheme
6-isopropylisoquinoline
790304-84-6

6-isopropylisoquinoline

1-(cyclohex-1-en-1-yl)-6-isopropylisoquinoline

1-(cyclohex-1-en-1-yl)-6-isopropylisoquinoline

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: acetic acid; dihydrogen peroxide / 12 h / 80 °C
2.1: trichlorophosphate / 6 h / 50 °C
3.1: potassium carbonate / tetrahydrofuran / 0.5 h / Inert atmosphere
3.2: 12 h / 80 °C / Inert atmosphere
View Scheme
6-isopropylisoquinoline
790304-84-6

6-isopropylisoquinoline

6-isopropyl-1-(3-methylcyclohex-1-en-1-yl)isoquinoline

6-isopropyl-1-(3-methylcyclohex-1-en-1-yl)isoquinoline

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: acetic acid; dihydrogen peroxide / 12 h / 80 °C
2.1: trichlorophosphate / 6 h / 50 °C
3.1: potassium carbonate / tetrahydrofuran / 0.5 h / Inert atmosphere
3.2: 12 h / 80 °C / Inert atmosphere
View Scheme
6-isopropylisoquinoline
790304-84-6

6-isopropylisoquinoline

C20H25N

C20H25N

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: acetic acid; dihydrogen peroxide / 12 h / 80 °C
2.1: trichlorophosphate / 6 h / 50 °C
3.1: potassium carbonate / tetrahydrofuran / 0.5 h / Inert atmosphere
3.2: 12 h / 80 °C / Inert atmosphere
View Scheme
6-isopropylisoquinoline
790304-84-6

6-isopropylisoquinoline

C72H80Cl2Ir2N4

C72H80Cl2Ir2N4

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: acetic acid; dihydrogen peroxide / 12 h / 80 °C
2.1: trichlorophosphate / 6 h / 50 °C
3.1: potassium carbonate / tetrahydrofuran / 0.5 h / Inert atmosphere
3.2: 12 h / 80 °C / Inert atmosphere
4.1: 2-ethoxy-ethanol; water / 24 h / Reflux
View Scheme

790304-84-6Relevant articles and documents

Red phosphorescent compound and organic light emitting diode device using red phosphorescent compound

-

Paragraph 0052; 0053; 0054, (2019/01/24)

The present invention discloses a red phosphorescent compound and an organic light emitting diode device using the red phosphorescent compound. The red phosphorescent compound having the structural formula as shown in I, wherein R1, R2, R3 and R4 are independently selected from one of H and C1 to C6 alkyl groups; in the formula (I), a group shown in the specification is selected one the group consisting of a specific alkanedione and a derivative thereof. The organic light emitting diode device includes a positive pole, a hole injecting layer, a hole transporting layer, a light emitting layer,an electron transporting layer, an electron injecting layer and a negative pole which are sequentially deposited; the organic light emitting diode device comprises the red phosphorescent compound as adopant. The red phosphorescent compound enables the organic light emitting diode device to have high efficiency and high color purity and narrow spectrum.

SULFONAMIDE DERIVATIVES AND USE THEREOF FOR THE MODULATION OF METALLOPROTEINASES

-

Page/Page column 63, (2008/06/13)

The present invention is related to sulfonamide derivatives of Formula (Ia) where the groups are as defined in the description, and use thereof in particular for the treatment and/or prophylaxis of autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, cancer, respiratory diseases and fibrosis, including multiple sclerosis, arthritis, emphysema, chronic obstructive pulmonary disease, liver and pulmonary fibrosis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 790304-84-6